The Journal of Urology
Volume 180, Issue 3 , Pages 820-829 , September 2008

Association Between Hospital and Surgeon Radical Prostatectomy Volume and Patient Outcomes: A Systematic Review

  • Timothy J. Wilt

      Affiliations

    • Minnesota Evidence-based Practice Center, Minneapolis, Minnesota
    • Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research, Minneapolis, Minnesota
    • Corresponding Author InformationCorrespondence: Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research, One Veterans Dr., 111-0, Minneapolis, Minnesota 55417 (telephone: 612-467-2681; FAX: 612-467-2118).
  • ,
  • Tatyana A. Shamliyan

      Affiliations

    • Minnesota Evidence-based Practice Center, Minneapolis, Minnesota
    • University of Minnesota Clinical Outcomes Research Center, Minneapolis, Minnesota
  • ,
  • Brent C. Taylor

      Affiliations

    • Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research, Minneapolis, Minnesota
  • ,
  • Roderick MacDonald

      Affiliations

    • Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research, Minneapolis, Minnesota
  • ,
  • Robert L. Kane

      Affiliations

    • Minnesota Evidence-based Practice Center, Minneapolis, Minnesota
    • University of Minnesota Clinical Outcomes Research Center, Minneapolis, Minnesota

Received 31 December 2007

References 

  1. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407
  2. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(IV-):104
  3. Healthcare Cost and Utilization Project (U.S.) (United States Agency for Healthcare Research and Quality). http://www.ahrq.gov/data/hcup/Accessed May 1, 2008
  4. Behavioral Risk Factor Surveillance System Survey Data, 2005 (National Center for Chronic Disease Prevention and Health Promotion). http://www.cdc.gov/brfss/technical_infodata/surveydata/2005.htmAccessed May 1, 2008
  5. United States Cancer Statistics: 1999–2002 Incidence and Mortality Web-based Report Version (United States Cancer Statistics Working Group). Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2005;
  6. Chassin MR, Galvin RW. The urgent need to improve health care quality (Institute of Medicine National Roundtable on Health Care Quality). JAMA. 1998;280:1000
  7. Nuttall M, van der Meulen J, Phillips N, Sharpin C, Gillatt D, McIntosh G, et al. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures. J Urol. 2004;172:2145
  8. Joudi FN, Konety BR. The impact of provider volume on outcomes from urological cancer therapy. J Urol. 2005;174:432
  9. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? (A systematic review and methodologic critique of the literature). Ann Intern Med. 2002;137:511
  10. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128
  11. Goff V. Advancing Patient Safety: The Leapfrog Group. In: Washington, D. C: National Health Care Purchasing Institute; 2001;p. 4
  12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting (Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group). JAMA. 2000;283:2008
  13. The Cochrane CollaborationHiggins J, Green S. The Cochrane Handbook for Systematic Reviews of Interventions. Chichester, United Kingdom: John Wiley and Sons; 2005;
  14. Gagliardi AR, Fleshner N, Langer B, Stern H, Brown AD. Development of prostate cancer quality indicators: a modified Delphi approach. Can J Urol. 2005;12:2808
  15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557
  16. Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in Stata. In:  Egger M,  Smith GD,  Altman DG editor. Systematic Reviews in Health Care: Meta Analysis in Context. London: BMJ Books; 2001;p. 347–369
  17. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, North Carolina: SAS Publishing; 1996;
  18. Begg CB, Riedel ER, Bach PB, Kattan MW, Schrag D, Warren JL, et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 2002;346:1138
  19. Ellison LM, Heaney JA, Birkmeyer JD. The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol. 2000;163:867
  20. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol. 2003;21:401
  21. Yao SL, Lu-Yao G. Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay. J Natl Cancer Inst. 1999;91:1950
  22. Wennberg JE, Roos N, Sola L, Schori A, Jaffe R. Use of claims data systems to evaluate health care outcomes (Mortality and reoperation following prostatectomy). JAMA. 1987;257:933
  23. Imperato PJ, Waisman J, Wallen M, Pryor V, Starr H, Rojas M, et al. The use of quality indicators for assessing radical prostatectomy specimens. Am J Med Qual. 2000;15:212
  24. Ellison LM, Trock BJ, Poe NR, Partin AW. The effect of hospital volume on cancer control after radical prostatectomy. J Urol. 2005;173:2094
  25. Bianco FJ, Riedel ER, Begg CB, Kattan MW, Scardino PT. Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol. 2005;173:2099
  26. Konety BR, Allareddy V, Modak S, Smith B. Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better?. J Clin Oncol. 2006;24:2006
  27. Yuan Z, Cooper GS, Einstadter D, Cebul RD, Rimm AA. The association between hospital type and mortality and length of stay: a study of 16.9 million hospitalized Medicare beneficiaries. Med Care. 2000;38:231
  28. Bubolz T, Wasson JH, Lu-Yao G, Barry MJ. Treatments for prostate cancer in older men: 1984–1997. Urology. 2001;58:977
  29. Brandeis J, Pashos CL, Henning JM, Litwin MS. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer. 2000;89:1792
  30. Litwin MS, Pasta DJ, Stoddard ML, Henning JM, Carroll PR. Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993. J Urol. 1998;160:445
  31. Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ. 2002;325:740
  32. Saigal CS, Pashos CL, Henning JM, Litwin MS. Variations in use of imaging in a national sample of men with early-stage prostate cancer. Urology. 2002;59:400
  33. Hernandez DJ, Epstein JI, Trock BJ, Tsuzuki T, Carter HB, Walsh PC. Radical retropubic prostatectomy (How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle?). J Urol. 2005;173:446
  34. Dash A, Dunn RL, Resh J, Wei JT, Montie JE, Sanda MG. Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: multivariate nomogram to assist patient counseling. Urology. 2004;64:117
  35. Gheiler EL, Lovisolo JA, Tiguert R, Tefilli MV, Grayson T, Oldford G, et al. Results of a clinical care pathway for radical prostatectomy patients in an open hospital-multiphysician system. Eur Urol. 1999;35:210
  36. Litwiller SE, Djavan B, Klopukh BV, Richier JC, Roehrborn CG. Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984–1994) (Dallas Outcomes Research Group for Urological Disorders). Urology. 1995;45:813
  37. Leibman BD, Dillioglugil O, Abbas F, Tanli S, Kattan MW, Scardino PT. Impact of a clinical pathway for radical retropubic prostatectomy. Urology. 1998;52:94
  38. Eastham JA, Kattan MW, Riedel E, Begg CB, Wheeler TM, Gerigk C, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol. 2003;170:2292
  39. Gaylis FD, Friedel WE, Armas OA. Radical retropubic prostatectomy outcomes at a community hospital. J Urol. 1998;159:167
  40. Karakiewicz PI, Bazinet M, Aprikian AG, Tanguay S, Elhilali MM. Thirty-day mortality rates and cumulative survival after radical retropubic prostatectomy. Urology. 1998;52:1041
  41. Krupski TL, Kwan L, Litwin MS. Sociodemographic factors associated with postprostatectomy radiotherapy. Prostate Cancer Prostatic Dis. 2005;8:184
  42. Kahn KL, Brook RH, Draper D, Keeler EB, Rubenstein LV, Rogers WH, et al. Interpreting hospital mortality data (How can we proceed?). JAMA. 1988;260:3625
  43. Recommendations for the reporting of resected prostate carcinomas (Association of Directors of Anatomical and Surgical Pathology). Hum Pathol. 1996;27:321
  44. Denberg TD, Flanigan RC, Kim FJ, Hoffman RM, Steiner JF. Self-reported volume of radical prostatectomies among urologists in the USA. BJU Int. 2007;99:339
  45. Luft HS. The relation between surgical volume and mortality: an exploration of causal factors and alternative models. Med Care. 1980;18:940
  46. Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? (The empirical relation between surgical volume and mortality). N Engl J Med. 1979;301:1364
  47. Luft HS, Hunt SS, Maerki SC. The volume-outcome relationship: practice-makes-perfect or selective-referral patterns?. Health Serv Res. 1987;22:157
  48. Denberg TD, Melhado TV, Steiner JF. Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote. Cancer. 2006;107:620
  49. Denberg TD, Beaty BL, Kim FJ, Steiner JF. Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer. 2005;103:1819

 Supported by Contract 290-02-0009 from the Agency for Healthcare Research and Quality, United States Department of Health and Human Services.

 Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the United States Department of Health and Human Services.

PII: S0022-5347(08)01230-5

doi: 10.1016/j.juro.2008.05.010

The Journal of Urology
Volume 180, Issue 3 , Pages 820-829 , September 2008